Subscribe

Bank loans aren’t the cure-all for rising rates

They don't get much of a benefit unless short-term rates rise, Schwab strategist says

No bond sector has been hotter than bank loans this year, but investors who are loading up on them to protect from rising interest rates may be disappointed.
Bank loan mutual funds had more than $19 billion in net inflows this year through the end of April, the most of any bond fund category and up from $1.26 billion a year earlier, according to Morningstar Inc.
The loans have become popular thanks to their floating rates, which typically are tied to benchmarks such as the London Interbank Offered Rate.
The only problem is that those benchmarks are tied to short-term rates, while the market is being driven by long-term rates, said Kathy Jones, a fixed-income strategist at The Charles Schwab Corp.
“Bank loans aren’t necessarily a bad idea, but they’re not going to deliver the returns people are hoping for until short-term rates go up,” she said. “They’re not going to get a lot of benefit from long-term rates rising.”
Last month, long-term rates skyrocketed 25% to 2.13%, from 1.66% at the beginning of the month, as investors worried about the Federal Reserve slowing down its asset purchasing program this year.
The violent jerk upward caused losses across every bond fund category at Morningstar except bank loans, which finished the month virtually flat.
The outperformance, however, is largely thanks to their relatively high yields and the fact that they are short-term bonds, rather than benefiting from rising rates, Ms. Jones said.
“Bank loans may not hurt you, but they may not help, either,” she said. “We don’t want people to be disappointed.”
Bank loans won’t see a benefit from rising rates until the Fed starts moving short-term interest rates, which it has kept near zero since 2008.
Such a move is incredibly unlikely as long as quantitative easing is still going on, Ms. Jones said.

Related Topics:

Learn more about reprints and licensing for this article.

Recent Articles by Author

Who will be alts’ best in show?

The demand for liquid alternatives has never been higher, and it is drawing in a pack of money managers who are all vying to be leaders of the pack.

One year on, iShares’ Core series clawing back market share for BlackRock

One year on, iShares' Core series is clawing back market share for BlackRock as price cuts, rebranding helps firm recover from case of “Vanguarditis.”

American Funds to expand sales force aggressively

The sales team will increase over the next six to eight months to help the company cope with the evolving adviser business model, said Matt O'Connor, director of distribution in North America.

American Funds makes push to increase transparency

Firm will share how portfolios are managed but won't reveal performance and holdings

Vanguard raked in almost every dollar that went into U.S. equity funds this year

If you bought a U.S. equity fund this year, there's about a 98% chance you invested in a fund managed by Vanguard. Jason Kephart has the story.

X

Subscribe and Save 60%

Premium Access
Print + Digital

Learn more
Subscribe to Print